Moderna market cap 2021

Stock analysis for Moderna Inc (MRNA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap. 52.318B. Day Range. 125.60 132

Last updated 2021/03/10 00:53 Oct 11, 2020 Feb 24, 2021 Feb 25, 2021 Jan 18, 2021 Aug 27, 2020 Dec 17, 2020 The medic Robert Gilbertson loads a syringe with the vaccine Moderna Covid-19. APU GOMES | AFP | Getty Images. Biotech and pharmaceutical company Moderna, a pioneer in developing coronavirus vaccines, has the potential to reach a market cap of over $ 100 billion, according to an analyst. Mar 09, 2021 Feb 26, 2021 Mar 01, 2021 Dec 10, 2020 Mar 02, 2021 Moderna’s stock was up 3% in pre-market trading Thursday as its fourth-quarter revenue of $ 571 million far exceeded estimates of $ 318.9 million, compared to $ 14 million in fourth quarter of 2019. It also forecast $ 18.4 billion in Covid-19 vaccine sales in 2021, having generated $ 199.87 million in Covid-19 vaccine sales in the fourth quarter. Moderna (NASDAQ:MRNA) Earnings Information. Moderna last released its quarterly earnings data on February 25th, 2021.

17.07.2021

with a $50 billion market cap, is a major player in the midstream segment, and operates a network of Jul 29, 2020 Jan 04, 2021 Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Moderna market cap as of March 05, 2021 is $52.85B. Compare MRNA With Other Stocks Moderna Therapeutics is pioneering a new class of drugs, messenger RNA Therapeutics, with the vast potential to treat many diseases across a range of drug modalities and therapeutic areas. Find out all the key statistics for Moderna, Inc. (MRNA), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Get the latest Moderna Inc (MRNA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Should you invest in Moderna (NasdaqGS:MRNA)? Flawless balance sheet with limited growth.

Moderna's Market Value Set to Rise by at Least 75%, Says Noted Analyst Oppenheimer's Hartaj Singh believes the stock's market capitalization is headed to at least $100 billion.

These are the stocks with the best value, fastest growth, and most momentum for of the total market capitalization of all listed stocks in the U.S. equity market. Moderna Inc.: Moderna is a clinical stage biotechnology company foc View the latest Moderna Inc. (MRNA) stock price, news, historical charts, analyst ratings and financial Moderna Inc. stock falls Wednesday, underperforms market Sales or Revenue 803.40 M MRNA will report Q1 earnings on 05/13/ But is the company's market value too lofty?

MRNA is good value based on its book value relative to its share price (20.05x), (NASDAQ: MRNA) Moderna's market cap is $51.34B, as of Mar 12, 2021.

Last Updated: Mar 12, 2021 10:09 a.m. EST Real time quote Market Cap $56.21B; Shares Outstanding 400.18M; Public Float 336.71M; Beta 0.25; Rev. per Employee $618.00K .. How Does the J&J Shot Change the Covid Vaccine Landscape? Mar 1, 2021 · Israel Approves Vaccinating Palestinian Workers With Moderna Jab. Feb 28, Check here latest Moderna Inc (mrna) share price, market cap, latest news, historical share price data, technical Market Close | 9:01 PM | 11 Mar 2021 Moderna's Market Value Set to Rise by at Least 75%, Says Noted Analyst. Oppenheimer's Hartaj Feb 25, 2021 at 5:00PM. Author Bio. Eric has been writing Moderna, Inc. Common Stock (MRNA) Stock Quotes - Nasdaq offers stock quotes & market activity DATA AS OF Mar 10, 2021 5:50 AM ET - PRE-MARKET.

Moderna’s shares rose 3% in premarket trade Thursday as its fourth-quarter revenue, of $517 million, vastly exceeded estimates of $318.9 million. It also forecast $18.4 billion in Covid-19 vaccine In depth view into Moderna Market Cap including historical data from 2018, charts, stats and industry comps. 2021: 52.32B March 8, 2021 : 49.36B Market Capitalization is expected to dwindle to about 7.3 B. From 2010 to 2021 Moderna Market Capitalization quarterly data regression line had arithmetic mean of 5,488,712,160 and slope of 207,239,765.

Moderna — $31 billion market value — is the only drugmaker in the Top 20 without an approved product. It’s clear Get the latest Moderna Inc (MRNA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Moderna has a market capitalization of $49.36 billion and generates $60.21 million in revenue each year. The company earns $-514,020,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. Next reporting date: May 13, 2021: EPS forecast (this quarter) $3.01: Annual revenue (last year) $803.4M: Annual profit (last year)-$747.1M: Net profit margin Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Moderna market cap as of March 05, 2021 is $52.85B. Compare MRNA With Other Stocks Feb 25, 2021 · Clinical worker Robert Gilbertson loads a syringe with the Moderna Covid-19 vaccine.

MRNA. Moderna, Inc. Common Stock. 118.97. 1.71. 1.46%. Delayed (15 Min) Trade Data: 01:07pm 01/12/2021. Overview · Quote Market Cap Market Cap. 25 Feb 2021 Moderna's total fourth-quarter revenue was US$571, according to the company, US$200 million of which came from vaccine sales, with other Актуальная информация по Moderna tokenized stock FTX (MRNA): цена, рыночная капитализация, торговые пары, Price; Market Cap; TradingView.

Day Range. 125.60 132 "If you put a 10-times-sales multiple on that then, you can do the math, then it's a $100-billion-plus market cap company," he added. Image source: Getty Images. Moderna rose to fame on mRNA-1273 Market Cap: 52.318B: Beta (5Y Monthly) 1.47: PE Ratio (TTM) N/A: EPS (TTM)-1.96: Earnings Date: May 05, 2021 - May 10, 2021: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Moderna named Fast Company’s Most Innovative Company for 2021. 2021. About Moderna.

generálny riaditeľ spoločnosti patricia bitcoin
zarobte na ťažbe bitcoinov
1,4 milióna dolárov v rupiách
ako vyplatiť veľa bitcoinov
ethereum calc
bitcoinová cena jablkových hodiniek
krypto summit bloomberg 2021

18 May 2020 We're not expecting any changes to our fair value estimates for Early Moderna Data Supports Vaccine by 2021 Editor's note: Read the latest on how the coronavirus is rattling the markets and what investors c

Moderna announced that they are set for shipping within 24 hours of the vaccine getting authorized. Medical worker Robert Gilbertson loads a syringe with the Moderna Covid-19 vaccine.APU GOMES | AFP | Getty ImagesBiotech and pharmaceutical company Moderna, a f $100 billion market cap is the blue-sky scenario for Moderna, analyst says - Stockxpo - A professional network of traders, investors and analysts Dec 18, 2020 Medical worker Robert Gilbertson loads a syringe with the Moderna Covid-19 vaccine. APU GOMES |… As of March 2021 Moderna has a market cap of $50.35 B. This makes Moderna the world's 334th most valuable company by market cap according to our data.

Market Cap. US$52.3b. Last Updated. Market. How volatile is . Moderna's share price compared to the market and industry in the last 5 years? 2021/03/09 00:00

there is a good chance Moderna will be profitable by the end of 2021. Moderna Rises; Biden Signs $1.9 Trillion Stimulus In weirder news, a digital artwork fetched more than $60 million at auction. By Susannah Snider , Senior Editor, Financial Advisors March 11, 2021 Enterprise Products Partners, with a $50 billion market cap, is a major player in the midstream segment, and operates a network of assets including more than 50,000 pipeline miles, storage Top Stocks to Buy in 2021; Stock Market News; and its market cap rose more than six-fold, from $6 billion to $41 billion. Of course, Gritstone is starting out with a much lower market Moderna has a market capitalization of $49.36 billion and generates $60.21 million in revenue each year. The company earns $-514,020,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. $100 billion market cap is the blue-sky scenario for Moderna, analyst says. Published Thu, Feb 25 20219:30 AM EST. Holly Ellyatt@HollyEllyatt.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. Medical worker Robert Gilbertson loads a syringe with the Moderna Covid-19 vaccine. APU GOMES |… Jul 20, 2020 · Shares of Moderna (ticker: MRNA) were up 385% so far this year as of the close of the market on Friday.